从肥胖引起的低度炎症到脂毒性和线粒体功能障碍:脂肪组织和代谢活跃器官之间的多重交叉变化
Gina Cavaliere1,2, Fabiano Cimmino2,3, Giovanna Trinchese3
1Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.
Antioxidants (Basel, Switzerland)
|June 28, 2023
概括
肥胖通过脂肪组织功能障碍和改变器官间通信驱动代谢疾病. 了解这些联系和生物活性食品成分为肥胖和相关疾病提供了治疗潜力.
科学领域:
- 代谢生理学 代谢生理学
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 肥胖是2型糖尿病,高脂血症,心血管疾病和神经疾病的主要危险因素.
- 人们越来越认识到,器官间代谢沟通对于肥胖的进展和相关疾病的发病至关重要.
- 脂肪组织功能障碍在肥胖和全身代谢变化的病因学中起着核心作用.
研究的目的:
- 提供全面的病理生理过程的概述,将脂肪组织功能障碍与肥胖症中多组织交叉交流的改变联系起来.
- 探索脂肪组织的作用,其不健康的扩张,以及相关因素,如炎症,代谢不灵活性和线粒体功能障碍.
- 讨论肥胖中的铁缺乏症以及生物活性食品成分在预防和治疗方面的潜力.
主要方法:
- 文献综述综合了关于脂肪组织生物学和代谢交叉交流的当前知识.
- 分析病理生理机制,包括炎症,代谢不灵活性和肥胖中的线粒体功能障碍.
- 对肥胖期间铁代谢中的肝-费罗波丁轴的检查以及饮食生物活性成分的作用.
主要成果:
- 脂肪组织功能障碍,以不健康的扩张和炎症为特征,破坏能量平衡.
- 脂肪组织中的代谢不灵活性和线粒体功能障碍有助于系统代谢失调.
- 铁缺乏症,与肝素-费罗波丁关系相关,是肥胖的一个显著问题,生物活性食品成分显示治疗承诺.
结论:
- 脂肪组织功能障碍和器官间通信障碍是肥胖和相关代谢疾病的关键驱动因素.
- 针对这些途径,以及管理铁状况和利用生物活性食品成分,对于治疗肥胖症至关重要.
- 对生物活性食品成分的进一步研究可以加强对与肥胖相关疾病的预防和治疗策略.
相关概念视频
Obesity
549
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
549
Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K


